MHRA approves catumaxomab to treat cancer-related fluid build-up in the abdomen
Imported from official source
As with all licensed medicines, the MHRA will keep the safety and effectiveness of catumaxomab under close review.
This version
- Version
- 1 of 1
- Recorded
- October 07, 2026 15:00
- Change
- Initial
- Content hash
5f305942e58b234d154df9e54b1bbb2d- All versions
- Revision history